CANDRIAM S.C.A. – Blueprint Medicines Corporation Transaction History
CANDRIAM S.C.A. portfolio value:
$17.02M
portfolio value
CANDRIAM S.C.A. quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.44% | 1.13K shares | 4.03M | $65.89 | 258.31K |
| Q2 2022 | share | Increase | +35.75% | 67.73K shares | 889K | $50.51 | 257.17K |
| Q1 2022 | share | Decrease | -46.22% | -162.80K shares | -25.62M | $63.88 | 189.44K |
| Q4 2021 | share | Increase | +12.56% | 39.29K shares | 5.55M | $109.45 | 352.24K |
| Q3 2021 | share | 0.00% | 0 shares | 4.64M | $102.81 | 312.95K | |
| Q2 2021 | share | Decrease | -11.06% | -38.93K shares | -10.38M | $87.96 | 312.95K |
| Q1 2021 | share | Decrease | -0.00% | -1 shares | -1.55M | $97.23 | 351.88K |
| Q4 2020 | share | Decrease | -34.11% | -182.13K shares | -10.03M | $112.15 | 351.88K |
| Q3 2020 | share | Decrease | -39.22% | -344.62K shares | -19.03M | $92.7 | 534.01K |
| Q2 2020 | share | Increase | +689.93% | 767.41K shares | 59.82M | $78 | 878.64K |
| Q1 2020 | share | Increase | +0.04% | 40 shares | -198K | $58.48 | 111.23K |
| Q4 2019 | share | Increase | 0.00% | 111.19K shares | 8.90M | $80.11 | 111.19K |
| Q4 2018 | share | Decrease | -100.00% | -45K shares | -3.51M | $53.91 | 0 |
| Q3 2018 | share | Increase | +2.27% | 1K shares | 720K | $78.06 | 45K |
| Q2 2018 | share | 0.00% | 0 shares | -1.24M | $63.48 | 44K | |
| Q1 2018 | share | 0.00% | 0 shares | 717K | $91.7 | 44K | |
| Q4 2017 | share | Increase | 0.00% | 44K shares | 3.31M | $75.41 | 44K |